Preclinical and clinical studies with combinations of pemetrexed and gemcitabine

被引：12

作者：

Adjei, AA ^{[1
]}

机构：

[1] Mayo Clin & Mayo Fdn, Div Med Oncol, Rochester, MN 55905 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期

关键词：

D O I：

10.1053/sonc.2002.37468

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：30 / 34

页数：5

共 19 条

[1] Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors [J].

Adjei, AA ;

Erlichman, C ;

Sloan, JA ;

Reid, JM ;

Pitot, HC ;

Goldberg, RM ;

Peethambaram, P ;

Atherton, P ;

Hanson, LJ ;

Alberts, SR ;

Jett, J .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) :1748-1757

[2] Pemetrexed: A multitargeted antifolate agent with promising activity in solid tumors [J].

Adjei, AA .

ANNALS OF ONCOLOGY, 2000, 11 (10) :1335-1341

[3]

ADJEI AA, 1998, 10 NCI EORTC S NEW D

[4]

CHEN VJ, 1996, P AM ASSOC CANC RES, V37, P2598

[5]

CRIPPS MC, 1997, EUR J CANC S8, V33

[6]

GREM JL, 1990, CANC CHEMOTHERAPY PR, P180

[7]

GRINDEY G B, 1992, Proceedings of the American Association for Cancer Research Annual Meeting, V33, P411

[8] Clinical, toxicological and pharmacological aspects of gemcitabine [J].

Guchelaar, HJ ;

Richel, DJ ;

vanKnapen, A .

CANCER TREATMENT REVIEWS, 1996, 22 (01) :15-31

[9]

Martin FN, 1999, CRIT REV PLANT SCI, V18, P111, DOI 10.1016/S0735-2689(99)00389-5

[10] A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancer [J].

Miles, DW ;

Smith, IE ;

Coleman, RE ;

Calvert, AH ;

Lind, MJ .

EUROPEAN JOURNAL OF CANCER, 2001, 37 (11) :1366-1371

← 1 2 →